Cypress Capital Management (Wyoming)’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-440
| Closed | -$67 | – | 219 |
|
|
2026
Q1 | $67 | Hold |
440
| – | – | ﹤0.01% | 201 |
|
|
2025
Q4 | $2 | Hold |
440
| – | – | ﹤0.01% | 207 |
|
|
2025
Q3 | $1 | Hold |
440
| – | – | ﹤0.01% | 179 |
|
|
2025
Q2 | $1 | Sell |
440
-10
| -2% | – | ﹤0.01% | 173 |
|
|
2025
Q1 | $0 | Buy |
+450
| New | – | ﹤0.01% | 173 |
|
|
2024
Q2 | – | Sell |
-461
| Closed | -$424 | – | 181 |
|
|
2024
Q1 | $424 | Sell |
461
-6
| -1% | -$10 | ﹤0.01% | 160 |
|
|
2023
Q4 | $957 | Sell |
467
-2
| -0.4% | -$5 | ﹤0.01% | 153 |
|
|
2023
Q3 | $1.71K | Buy |
469
+12
| +3% | +$52 | ﹤0.01% | 151 |
|
|
2023
Q2 | $2.13K | Sell |
457
-6
| -1% | -$29 | ﹤0.01% | 141 |
|
|
2023
Q1 | $2.16K | Hold |
463
| – | – | ﹤0.01% | 139 |
|
|
2022
Q4 | $2.09K | Sell |
463
-7
| -1% | -$45 | ﹤0.01% | 137 |
|
|
2022
Q3 | $9K | Sell |
470
-15
| -3% | -$525 | 0.01% | 115 |
|
|
2022
Q2 | $24K | Sell |
485
-113
| -19% | -$8.41K | 0.03% | 89 |
|
|
2022
Q1 | $84K | Sell |
598
-58
| -9% | -$8.47K | 0.1% | 65 |
|
|
2021
Q4 | $112K | Hold |
656
| – | – | 0.09% | 95 |
|
|
2021
Q3 | $327K | Sell |
656
-33
| -5% | -$15.3K | 0.27% | 58 |
|
|
2021
Q2 | $345K | Sell |
689
-26
| -4% | -$14K | 0.27% | 63 |
|
|
2021
Q1 | $363K | Hold |
715
| – | – | 0.32% | 56 |
|
|
2020
Q4 | $341K | Sell |
715
-88
| -11% | -$28.9K | 0.3% | 58 |
|
|
2020
Q3 | $211K | Sell |
803
-63
| -7% | -$15.6K | 0.19% | 70 |
|
|
2020
Q2 | $165K | Hold |
866
| – | – | 0.16% | 79 |
|
|
2020
Q1 | $108K | Sell |
866
-17
| -2% | -$3.08K | 0.15% | 64 |
|
|
2019
Q4 | $154K | Sell |
883
-140
| -14% | -$18.1K | 0.15% | 75 |
|
|
2019
Q3 | $154K | Buy |
1,023
+62
| +6% | +$8.26K | 0.18% | 67 |
|
|
2019
Q2 | $112K | Buy |
961
+180
| +23% | +$28.5K | 0.13% | 82 |
|
|
2019
Q1 | $132K | Buy |
781
+54
| +7% | +$9.25K | 0.18% | 70 |
|
|
2018
Q4 | $86K | Sell |
727
-349
| -32% | -$53.6K | 0.17% | 94 |
|
|
2018
Q3 | $164K | Buy |
1,076
+4
| +0.4% | +$1.67K | 0.16% | 97 |
|
|
2018
Q2 | $708K | Buy |
1,072
+517
| +93% | +$387K | 0.74% | 40 |
|
|
2018
Q1 | $566K | Buy |
555
+194
| +54% | +$162K | 0.65% | 40 |
|
|
2017
Q4 | $441K | Buy |
361
+121
| +50% | +$56.9K | 0.5% | 56 |
|
|
2017
Q3 | $44K | Hold |
240
| – | – | 0.05% | 137 |
|
|
2017
Q2 | $37.5K | Hold |
240
| – | – | 0.04% | 138 |
|
|
2017
Q1 | $57.6K | Buy |
240
+70
| +41% | +$18.8K | 0.07% | 111 |
|
|
2016
Q4 | $46.9K | Buy |
+170
| New | +$40.5K | 0.05% | 133 |
|
Cypress Capital Management (Wyoming)'s AMPE Position: Q2 2026 in Review
Cypress Capital Management (Wyoming) sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2026, closing a stake of 440 shares — an estimated $67 sold.
Cypress Capital Management (Wyoming) first reported a position in AMPE in Q4 2016 and held it in 35 quarters. The position peaked at $708K in Q2 2018. 0 funds tracked by Wall St. Rank hold AMPE as of Q2 2026.
- Cypress Capital Management (Wyoming) reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2026 after selling out during the quarter.
- Cypress Capital Management (Wyoming) sold 440 Ampio Pharmaceuticals Inc. shares in Q2 2026, an estimated $67.
- Cypress Capital Management (Wyoming) first reported a position in Ampio Pharmaceuticals Inc. in Q4 2016 and held it in 35 quarters.
- Cypress Capital Management (Wyoming)'s Ampio Pharmaceuticals Inc. position peaked at $708K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2026.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.